Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Bos taurus | Intestinal alkaline phosphatase | References | |
Homo sapiens | 5'-nucleotidase, ecto (CD73) | References | |
Rattus norvegicus | 5'-nucleotidase | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | alkaline phosphatase | 0.0196 | 0.4053 | 0.5 |
Echinococcus granulosus | intestinal type alkaline phosphatase | 0.0196 | 0.4053 | 0.5 |
Echinococcus granulosus | alkaline phosphatase intestinal gene 2 | 0.0196 | 0.4053 | 0.5 |
Schistosoma mansoni | alkaline phosphatase | 0.0196 | 0.4053 | 0.4053 |
Echinococcus granulosus | intestinal type alkaline phosphatase 1 | 0.0196 | 0.4053 | 0.5 |
Toxoplasma gondii | 5'-nucleotidase, C-terminal domain-containing protein | 0.0335 | 1 | 1 |
Echinococcus multilocularis | intestinal type alkaline phosphatase | 0.0196 | 0.4053 | 0.5 |
Echinococcus multilocularis | alkaline phosphatase, intestinal, gene 2 | 0.0196 | 0.4053 | 0.5 |
Schistosoma mansoni | 23-cyclic-nucleotide 2-phosphodiesterase | 0.0334 | 0.9959 | 0.9959 |
Schistosoma mansoni | alkaline phosphatase | 0.0196 | 0.4053 | 0.4053 |
Echinococcus multilocularis | intestinal type alkaline phosphatase 1 | 0.0196 | 0.4053 | 0.5 |
Echinococcus multilocularis | alkaline phosphatase | 0.0196 | 0.4053 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0137 | 0.1496 | 0.5 |
Treponema pallidum | 5'-nucleotidase (ushA) | 0.0335 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.56 uM | Inhibition of human Ecto-5'-nucleotidase transfected in COS7 cells preincubated for 10 mins followed by AMP addition measured after 10 mins | ChEMBL. | 27054295 |
IC50 (binding) | = 2.38 uM | Inhibition of rat Ecto-5'-nucleotidase transfected in COS7 cells preincubated for 10 mins followed by AMP addition measured after 10 mins | ChEMBL. | 27054295 |
IC50 (binding) | = 31.9 uM | Inhibition of calf intestinal alkaline phosphatase preincubated for 3 to 5 mins followed by CDP-star substrate addition measured after 15 mins by luminescence assay | ChEMBL. | 27054295 |
Inhibition (binding) | = 34.25 % | Inhibition of bovine tissue non-specific alkaline phosphatase at 0.2 mM preincubated for 3 to 5 mins followed by CDP-star substrate addition measured after 15 mins by luminescence assay | ChEMBL. | 27054295 |
Ki (binding) | = 0.027 uM | Inhibition of human Ecto-5'-nucleotidase transfected in COS7 cells preincubated for 10 mins followed by AMP addition measured after 10 mins | ChEMBL. | 27054295 |
Ki (binding) | = 0.113 uM | Inhibition of rat Ecto-5'-nucleotidase transfected in COS7 cells preincubated for 10 mins followed by AMP addition measured after 10 mins | ChEMBL. | 27054295 |
Ki (binding) | = 13.6 uM | Inhibition of calf intestinal alkaline phosphatase preincubated for 3 to 5 mins followed by CDP-star substrate addition measured after 15 mins by luminescence assay | ChEMBL. | 27054295 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.